• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Pneumococcal vaccine associated with a decrease in pneumonia hospitalizations

bys25qthea
July 10, 2013
in Chronic Disease, Infectious Disease, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Since the pneumococcal vaccine PCV7 was introduced in 2000, the US saw an overall annual reduction of an estimated 168,000 hospitalizations for pneumonia per year. 

2. The greatest reductions in annual hospitalization rates for pneumonia were at the extremes of age with children < 2 years old experiencing an estimated decline of 47,000 hospitalizations per year and adults > 85 years old experiencing a decline of 73,000 hospitalizations per year. 

3.  Much of the benefit in adults appears to have been indirect, through herd immunity as PCV7 was targeted toward young children, while adults accounted for most of the decline in overall hospitalizations. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The 7-valent pneumococcal conjugate vaccine (PCV7) was added to routine childhood immunizations in 2000.  Early studies had shown a significant reduction in pneumococcal disease in the United States starting in 2000.  However, it was not known if these reductions would be sustained, and further studies suggested that a rise in pneumoccocus serotype 19A infections – a serotype not covered by the vaccine – may have diminished the initial success of the vaccine.  This study, however, seems to provide reassurance that the vaccine has significantly reduced the overall burden of pneumococcal disease in the United States.  Perhaps most interesting is the fact that the vaccine was targeted toward young children, but that adults experienced the most dramatic reductions in hospitalizations.  This reduction it would appear is due to the vaccine’s severing of the chain of infection and providing an overall ‘herd immunity.’  Going forward, the PCV13 vaccine has now replaced the PCV7 vaccine, and further studies should explore the effects of the added serotypes.

Click to read the study, published today in NEJM

RELATED REPORTS

Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

Clinical response to Gram stain-guided antibiotic therapy noninferior to that of guideline-based therapy in patients with ventilator-associated pneumonia

Relevant Reading: Sustained reductions in invasive pneumococcal disease

In-Depth [retrospective cohort study]: This study sought to determine if previously observed reductions in pneumonia hospitalizations were sustained for the decade after the introduction of PCV7.  The authors drew data from the Nationwide Inpatient Sample database (NIS), which gathers data from approximately 8 million hospitalizations annually from hospitals throughout the United States.  Pneumonia hospitalizations were determined using ICD-9-CM codes.  Inpatient data was gathered from 1997-2009.  The data was used to estimate annual pneumonia hospitalizations among different age groups and was stratified by time period; 1997-1999 (Pre-PCV7), 2001-2006 (Early PCV7) and 2007-2009 (Late PCV7).  Pneumonia hospitalization rates for children under 2 declined substantially during the Early and Late PCV7 time periods, while older children showed minimal changes.  Adults also displayed sustained reductions in pneumonia hospitalizations beginning in 2000, with the greatest reduction occurring in adults older than 85.  The overall annual reduction of pneumonia hospitalizations among all age groups was an estimated 168,000 per year.

By Akira Shishido, M.D. and Mitalee Patil

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: immunizationPneumococcalpneumoniavaccinevaccines
Previous Post

Rates of major CV procedures differ between Medicare Advantage and fee-for-service beneficiaries

Next Post

Alternative treatment for acute promyelocytic leukemia promising

RelatedReports

Clinical practice guidelines linked to improved bronchiolitis outcomes
Infectious Disease

Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women

May 13, 2022
Preterm infants responsive to PCV13 vaccine
Infectious Disease

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

May 10, 2022
Prescription of antibiotics for acute respiratory infections increasing
Infectious Disease

Clinical response to Gram stain-guided antibiotic therapy noninferior to that of guideline-based therapy in patients with ventilator-associated pneumonia

April 14, 2022
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

DNA-based vaccine, ZyCoV-D, is safe and efficacious against COVID-19 infection for patients aged 12 years and older

April 12, 2022
Next Post
Alternative treatment for acute promyelocytic leukemia promising

Alternative treatment for acute promyelocytic leukemia promising

The PIVOT trial: Radical prostatectomy versus observation [Classics Series]

Gestational weight loss may improve outcomes for obese women

African Americans, obese overrepresented in young heart failure cases

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.